SMLR Quote, Financials, Valuation and Earnings

Picard Medical has a net margin of -732.34% compared to Semler Scientific, Inc.'s net margin of --. Semler Scientific, Inc.'s return on equity of 18.3% beat Picard Medical's return on equity of --.

Semler Scientific, Inc. has a consensus price target of $65.67, signalling upside risk potential of 278.48%. On the other hand Picard Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that Semler Scientific, Inc. has higher upside potential than Picard Medical, analysts believe Semler Scientific, Inc. is more attractive than Picard Medical.

Semler Scientific, Inc. has a beta of 1.348, which suggesting that the stock is 34.774% more volatile than S&P 500. In comparison Picard Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Semler Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Picard Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Semler Scientific, Inc. pays -- of its earnings as a dividend. Picard Medical pays out -- of its earnings as a dividend.

Semler Scientific, Inc. quarterly revenues are $7.5M, which are larger than Picard Medical quarterly revenues of --. Semler Scientific, Inc.'s net income of $16.9M is higher than Picard Medical's net income of --. Notably, Semler Scientific, Inc.'s price-to-earnings ratio is 6.24x while Picard Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Semler Scientific, Inc. is 5.66x versus -- for Picard Medical. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of -732.34% compared to Semler Scientific, Inc.'s net margin of -862.39%. Semler Scientific, Inc.'s return on equity of 18.3% beat VolitionRX Ltd.'s return on equity of --.

Semler Scientific, Inc. has a consensus price target of $65.67, signalling upside risk potential of 278.48%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 773.02%. Given that VolitionRX Ltd. has higher upside potential than Semler Scientific, Inc., analysts believe VolitionRX Ltd. is more attractive than Semler Scientific, Inc..

Semler Scientific, Inc. has a beta of 1.348, which suggesting that the stock is 34.774% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

Semler Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Semler Scientific, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

Semler Scientific, Inc. quarterly revenues are $7.5M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Semler Scientific, Inc.'s net income of $16.9M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Semler Scientific, Inc.'s price-to-earnings ratio is 6.24x while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Semler Scientific, Inc. is 5.66x versus 17.27x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision, Inc. has a net margin of -732.34% compared to Semler Scientific, Inc.'s net margin of -1037.17%. Semler Scientific, Inc.'s return on equity of 18.3% beat Catheter Precision, Inc.'s return on equity of -192.05%.

Semler Scientific, Inc. has a consensus price target of $65.67, signalling upside risk potential of 278.48%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 2034.9%. Given that Catheter Precision, Inc. has higher upside potential than Semler Scientific, Inc., analysts believe Catheter Precision, Inc. is more attractive than Semler Scientific, Inc..

Semler Scientific, Inc. has a beta of 1.348, which suggesting that the stock is 34.774% more volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.

Semler Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Semler Scientific, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.

Semler Scientific, Inc. quarterly revenues are $7.5M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Semler Scientific, Inc.'s net income of $16.9M is higher than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Semler Scientific, Inc.'s price-to-earnings ratio is 6.24x while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Semler Scientific, Inc. is 5.66x versus 8.37x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -732.34% compared to Semler Scientific, Inc.'s net margin of 3.93%. Semler Scientific, Inc.'s return on equity of 18.3% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Semler Scientific, Inc. has a consensus price target of $65.67, signalling upside risk potential of 278.48%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 92.8%. Given that Semler Scientific, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Semler Scientific, Inc. is more attractive than Xtant Medical Holdings, Inc..

Semler Scientific, Inc. has a beta of 1.348, which suggesting that the stock is 34.774% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

Semler Scientific, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Semler Scientific, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Semler Scientific, Inc. quarterly revenues are $7.5M, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Semler Scientific, Inc.'s net income of $16.9M is higher than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Semler Scientific, Inc.'s price-to-earnings ratio is 6.24x while Xtant Medical Holdings, Inc.'s PE ratio is 76.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Semler Scientific, Inc. is 5.66x versus 0.85x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.